SPOTLIGHT -
This year saw the approval of new therapies as well as the continued evolution of time-to-treat infections and updated guidelines.
During the Pandemic, 75% of Hospitalized COVID-19 Patients Received Antibiotics, Despite Only a Minority Needing Them
The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections
Prompts in Computerized Ordering Reduced Empiric Use of Broad-Spectrum Antibiotics
Expert Guidance on Managing Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in an Outpatient Setting
Cefiderocol Demonstrates Efficacy Against Pseudomonas in Immunocompromised
Harnessing CRISPR to Battle Antimicrobial Resistance